Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer
Clinical trial NCT05176080 · TERMINATED
Trial details
- NCT number
- NCT05176080
- Sponsor
- Henan Cancer Hospital
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-08
- Primary completion
- 2024-07-03
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.